InvestorsHub Logo
Followers 1006
Posts 43317
Boards Moderated 0
Alias Born 03/17/2014

Re: None

Tuesday, 08/08/2023 6:18:17 PM

Tuesday, August 08, 2023 6:18:17 PM

Post# of 5001
Maxim Group Upgrades Vistagen Therapeutics to Buy, Announces $30 Price Target
7:09 pm ET August 7, 2023 (Benzinga) Print
Maxim Group analyst Jason McCarthy upgrades Vistagen Therapeutics (NASDAQ:VTGN) from Hold to Buy and announces $30 price target.

Latest Ratings for VTGN DateFirmActionFromTo

May 2021BairdInitiates Coverage OnOutperform Feb 2021JefferiesInitiates Coverage OnBuy Jan 2021William BlairUpgradesMarket PerformOutperform

View More Analyst Ratings for VTGN

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News